Palisade Bio Welcomes New Board Member, Eyes Strategic Growth
Company Announcements

Palisade Bio Welcomes New Board Member, Eyes Strategic Growth

Palisade Bio (PALI) has provided an announcement.

In a significant corporate update, the Company has announced the addition of Margery Fischbein to its Board, signaling a move that could potentially bring fresh perspectives and strategic insights to its operations. This development was publicized through a recent press release, reflecting the Company’s ongoing commitment to leadership enhancement.

Learn more about PALI stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyPalisade Bio price target lowered to $8 from $22.50 at Maxim
TheFlyPalisade Bio reports Q3 EPS ($2.32) vs. ($7.38) last year
TheFlyPalisade Bio expects cash to fund operations through 1Q25
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App